Tilray Brands Inc (TLRY): Next-Year EPS Estimate 45.99%
As of 2026-06-04, Tilray Brands Inc (TLRY) has a next-year EPS growth estimate of 45.99%.
On 2026-04-27, analyst consensus for TLRY's next-year EPS growth shifted from 45.94% to 45.99% — a positive change of 0.05 percentage points. The revised estimate has been sustained across 29 subsequent trading sessions. Current-year growth is projected at 97.50%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 45.99%
- EPS growth this year
- 97.50%
- EPS next quarter (est)
- -$0.01
- Last price
- $5.19
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 45.99% | 97.50% | -$0.01 | $5.19 |
| 2026-06-03 | 45.99% | 97.50% | -$0.01 | $5.11 |
| 2026-06-02 | 45.99% | 97.50% | -$0.01 | $5.38 |
| 2026-06-01 | 45.99% | 97.50% | -$0.01 | $5.49 |
| 2026-05-31 | 45.99% | 97.50% | -$0.01 | $5.51 |
| 2026-05-28 | 45.99% | 97.50% | -$0.01 | $5.65 |
| 2026-05-27 | 45.99% | 97.50% | -$0.01 | $5.55 |
| 2026-05-26 | 45.99% | 97.50% | -$0.01 | $5.45 |
| 2026-05-25 | 45.99% | 97.50% | -$0.01 | $5.29 |
| 2026-05-24 | 45.99% | 97.50% | -$0.01 | $5.29 |
| 2026-05-21 | 45.99% | 97.50% | -$0.01 | $5.46 |
| 2026-05-20 | 45.99% | 97.50% | -$0.01 | $5.41 |
| 2026-05-19 | 45.99% | 97.50% | -$0.01 | $5.21 |
| 2026-05-18 | 45.99% | 97.50% | -$0.01 | $5.18 |
| 2026-05-17 | 45.99% | 97.50% | -$0.01 | $5.32 |
| 2026-05-14 | 45.99% | 97.50% | -$0.01 | $5.50 |
| 2026-05-13 | 45.99% | 97.50% | -$0.01 | $5.48 |
| 2026-05-12 | 45.99% | 97.50% | -$0.01 | $5.41 |
| 2026-05-11 | 45.99% | 97.50% | -$0.01 | $5.51 |
| 2026-05-10 | 45.99% | 97.50% | -$0.01 | $5.56 |
| 2026-05-07 | 45.99% | 97.50% | -$0.01 | $5.66 |
| 2026-05-06 | 45.99% | 97.50% | -$0.01 | $5.76 |
| 2026-05-05 | 45.99% | 97.50% | -$0.01 | $5.69 |
| 2026-05-04 | 45.99% | 97.50% | -$0.01 | $5.90 |
| 2026-05-03 | 45.99% | 97.50% | -$0.01 | $6.16 |
| 2026-04-30 | 45.99% | 97.50% | -$0.01 | $6.24 |
| 2026-04-29 | 45.99% | 97.50% | -$0.01 | $6.14 |
| 2026-04-28 | 45.99% | 97.50% | -$0.01 | $6.56 |
| 2026-04-27 | 45.99% | 97.50% | -$0.01 | $6.89 |
| 2026-04-26 | 45.94% | 97.50% | -$0.01 | $6.75 |
Recent News
- The cannabis rescheduling is causing celebration - and confusion - as marijuana stocks sell offMarketWatch
- Medical Marijuana Reclassified as Less Dangerous Drug. Pot Stocks Take a Breather.Barrons.com
- Pot firms reverse gains on narrow scope of US reschedulingReuters Videos
- Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey-A Must-Try for Whiskey EnthusiastsGlobeNewswire
- Weekly Roundup on the Cannabis Sector & Psychedelic SectorMarket Exclusive
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Tilray Brands Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Tilray Brands Inc (TLRY) has a next-year EPS growth estimate of 45.99%, based on analyst consensus.
When was the latest EPS estimate revision for TLRY?▾
The most recent revision occurred on 2026-04-27, when analysts adjusted the next-year EPS growth estimate from 45.94% to 45.99%.
What sector and industry does Tilray Brands Inc belong to?▾
Tilray Brands Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TLRY appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Tilray Brands Inc (TLRY) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports